ZANGAGLIA, ROBERTA
 Distribuzione geografica
Continente #
NA - Nord America 606
EU - Europa 340
AS - Asia 54
OC - Oceania 2
AF - Africa 1
Totale 1.003
Nazione #
US - Stati Uniti d'America 603
IE - Irlanda 219
FI - Finlandia 40
DE - Germania 37
CN - Cina 30
IT - Italia 15
CZ - Repubblica Ceca 14
SG - Singapore 10
IN - India 6
BE - Belgio 5
JP - Giappone 5
UA - Ucraina 5
CA - Canada 3
SE - Svezia 3
AU - Australia 2
RO - Romania 2
TW - Taiwan 2
MU - Mauritius 1
SA - Arabia Saudita 1
Totale 1.003
Città #
Chandler 215
Dublin 211
Ashburn 41
Helsinki 38
Wilmington 28
Lawrence 26
Medford 26
Princeton 26
New York 24
Shanghai 20
Boardman 13
Brno 13
Ann Arbor 12
Piscataway 9
Falls Church 8
Fairfield 7
Menlo Park 7
Chicago 6
Jacksonville 6
Singapore 6
Brussels 5
Los Angeles 5
Pune 5
Seattle 5
Tokyo 5
Milan 4
Norwalk 4
Washington 4
Andover 3
Clifton 3
Tianjin 3
Toronto 3
Falkenstein 2
Hsinchu 2
Nanjing 2
Shijiazhuang 2
Austin 1
Berlin 1
Borås 1
Böblingen 1
Cambridge 1
Cedar Knolls 1
Cologne 1
Esslingen am Neckar 1
Hangzhou 1
Hanover 1
Hunters Hill 1
Mainz 1
Nanchang 1
Olomouc 1
Pavia 1
Redwood City 1
Rognano 1
Rome 1
Tappahannock 1
Vancouver 1
Woodbridge 1
Totale 820
Nome #
Botulinum toxin treatment for functional disability induced by essential tremor. 62
Consensus on the treatment of dysphagia in Parkinson's disease 58
Substantia Nigra Volumetry with 3-T MRI in De Novo and Advanced Parkinson Disease 48
Gba mutations influence the release and pathological effects of small extracellular vesicles from fibroblasts of patients with parkinson’s disease 44
Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells 43
PSEN1 Compound Heterozygous Mutations Associated with Cerebral Amyloid Angiopathy and Cognitive Decline Phenotype 43
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 42
TUBB4A-related hypomyelinating leukodystrophy: New insights from a series of 12 patients 40
Extracellular Vesicles Derived From Plasma of Patients With Neurodegenerative Disease Have Common Transcriptomic Profiling 40
Lumboperitoneal shunt in idiopathic normal pressure hydrocephalus: a prospective controlled study 38
Copper deficiency in Wilson's disease: Peripheral neuropathy and myelodysplastic syndrome complicating zinc treatment 38
Complex paroxysmal nocturnal behaviors in Parkinson's disease 38
Monitoring late complications of zinc treatment in Wilson's disease. Reply to the letter: Copper deficiency in Wilson's disease: An avoidable complication of treatment: Monitoring Late Complications of Zinc Treatment in Wilson's Disease 37
A multinational consensus on dysphagia in Parkinson's disease: screening, diagnosis and prognostic value 37
Vocal cord electromyographic correlates of stridor in multiple system atrophy phenotypes 36
Different miRNA profiles in plasma derived small and large extracellular vesicles of neurodegenerative disease patients. 36
The exosomal/total α-synuclein ratio in plasma is associated with glucocerebrosidase activity and correlates with measures of disease severity in PD patients 35
Treating sleep apnea in Parkinson's disease with C-PAP: feasibility concerns and effects on cognition and alertness 35
Agrypnia with nocturnal confusional behaviors in dementia with lewy bodies: immediate efficacy of rivastigmine 35
Bioenergetic and proteolytic defects in fibroblasts from patients with sporadic Parkinson's disease 35
Analysis of video-polysomnographic sleep findings in dementia with Lewy bodies 34
Neurophysiological evaluation of visual function in iRBD: potential role in stratifying RBD conversion risk 34
Hallucinations and REM sleep behaviour disorder in Parkinson's disease: Dream imagery intrusions and other hypotheses 32
Reproducibility and reaction time of swallowing as markers of dysphagia in parkinsonian syndromes 31
Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease 31
REM and NREM sleep enactment behaviors in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies 29
Calcium homeostasis is dysregulated in Parkinsonian patients with L-DOPA-induced dyskinesias 27
Totale 1.038
Categoria #
all - tutte 5.129
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.129


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011 2 4 0 1 0 1 0 1 0 1 1 0
2020/202153 1 1 4 5 5 3 7 10 7 7 2 1
2021/2022163 1 1 1 16 10 10 3 13 9 1 18 80
2022/2023542 53 54 8 52 38 49 0 27 242 3 7 9
2023/2024229 33 49 7 6 8 64 5 13 3 7 15 19
2024/202533 33 0 0 0 0 0 0 0 0 0 0 0
Totale 1.038